Report Highlights
Global Minimally Invasive Gastrointestinal Surgical Systems Market to Reach $10.4 Billion by 2031.
Market Report Coverage - Minimally Invasive Gastrointestinal Surgical Systems
Market Segmentation
- Product Type – Conventional Minimally Invasive Gastrointestinal Surgical Systems (MISS)[Endoscopes and Endoscopy Systems, Videoscopes, Endoscopic Ultrasound, Therapeutic Energy Devices], Surgical Robotics (Robotic Systems, Robotic Surgery Instruments and Accessories, Services)
- Surgery – Adrenalectomy, Appendectomy, Bariatric Surgery, Cholecystectomy, Colon and Rectal Surgery, Foregut Surgery, Hernia Repair
- End User – Conventional Technologies (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), Surgical Robotics (Hospitals, Ambulatory Surgical Centers, Specialty Clinics)
Regional Segmentation
- North America: U.S. and Canada
- Europe: Germany, U.K, Italy, Spain, France, and Rest-of-Europe
- Asia-Pacific: Japan, China, India, South Korea, Australia and New Zealand, and Rest-of-Asia-Pacific
- Rest-of-the-World
Growth Drivers
- Advantages of Minimally Invasive Surgical Procedures Over Conventional Open Surgical Procedures
- Availability of Technological Advanced Products in the Field of GI Surgical Procedures
- Increasing Healthcare Spending
- Growth in Robotics GI Surgical Procedures
Market Challenges
- High Cost of Minimally Invasive GI Surgical Procedures
- Shortage of Skilled Professionals
- Restrictive Reimbursement Framework
Market Opportunities
- Development of Long-Distance Teleoperated Surgical Robotic Systems
- Mergers and Acquisitions to Diversify Endoscopic Portfolio
- Investment for Regional Expansions
Key Companies Profiled
Ambu A/S, B. Braun Melsungen AG, Boston Scientific Corporation, Conmed Corporation, Cook Medical Inc., Intuitive Surgical, Inc., Olympus Corporation, Medtronic plc, Karl Storz SE & Co. KG, Stryker Corporation, Schölly Fiberoptic GmbH, Xenocor Inc., Fujifilm Holdings Corporation, Pentax Medical (Hoya Corporation), Richard Wolf GmbH, and TransEnterix, Inc.
Key Questions Answered in this Report:
- What is the current market size and future potential of these products?
- What is the current market share and growth share of the different products in the market?
- What are the guidelines implemented by different government bodies to regulate the approval of minimally invasive gastrointestinal surgical systems?
- What are the major market drivers, restraints, and opportunities in the global minimally invasive gastrointestinal surgical systems market?
- What is the impact of the COVID-19 pandemic on the market?
- Which technology is being researched and worked upon to improve the gastrointestinal surgical systems?
- Who are the leading players dominating the global minimally invasive gastrointestinal surgical systems market?
- What are the key development and strategies incorporated by the players of global minimally invasive gastrointestinal surgical systems market, to sustain the competition and retain their supremacy?
- Which countries contribute to the major share of current demand and which countries hold significant scope for expansion for business activities, by players of the global minimally invasive gastrointestinal surgical systems market?
- How advanced technologies such as surgical robotics is gaining traction in terms of market share in in gastrointestinal space?
Overview on the Global Minimally Invasive Gastrointestinal Surgical Systems Market
The global minimally invasive gastrointestinal surgical systems market is currently witnessing a significant change in the market landscape. There is rising investment in the development of healthcare infrastructure, increasing evidence for efficient and promising results in surgery assistance. Thus, this is leading to potential growth opportunities for the minimally invasive gastrointestinal surgical systems market. Moreover, there is an extensive entry of emerging players developing MIS surgical systems. All these predominant factors have led to a significant rise in sales of minimally invasive gastrointestinal surgical systems across the globe.
Global Minimally Invasive Gastrointestinal Surgical Systems Market (2020-2031)
The global minimally invasive gastrointestinal surgical systems market was valued at $5,021.8 million in 2020 and is anticipated to reach $10,441.0 million by 2031, growing at a CAGR of 6.8% during the forecast period 2021-2031. The increasing complexities in clinical decision-making, rising radiologist workload, and huge R&D investments are the major factors fueling the market growth. In addition to these factors, there are significant challenges and restraints, which are restricting the market growth. These challenges include the shortage of skilled professionals, high cost of minimally invasive GI surgical procedures, and restrictive reimbursement framework. Hence, it is anticipated that these trends will have a significant impact on the minimally invasive gastrointestinal surgical systems market in the during the forecast period, and the market will grow multifold.
Competitive Landscape
The global minimally invasive gastrointestinal surgical systems market consists of numerous large-scale as well as small-scale manufacturers and vendors. Presently, with the increasing adoption of technologies in healthcare, the manufacturers in the market have an ample number of opportunities to expand their offerings and to establish a strong foothold in the market.
From January 2015 to January 2021, the market witnessed approximately 25 regulatory and legal developments, 11 new offerings, 44 partnerships, alliances, and business expansions, four funding activities, and seven mergers and acquisitions activities. Joint ventures, collaborations, and partnerships were among the most frequently followed strategies incorporated by numerous players to establish a strong foothold in the market.
Most of the manufacturers in the market are incorporating collaborations and partnerships with not only other companies but also the university and research institutions as the key strategies to develop novel minimally invasive gastrointestinal surgical systems and attain a strong financial position in the market.
The leading imaging modality providers in the global minimally invasive gastrointestinal surgical systems market include Ambu A/S, B. Braun Melsungen AG, Boston Scientific Corporation, Conmed Corporation, Cook Medical Inc., Intuitive Surgical, Inc., Olympus Corporation, Medtronic plc, Karl Storz SE & Co. KG, Stryker Corporation, Schölly Fiberoptic GmbH, Xenocor Inc., Fujifilm Holdings Corporation, Pentax Medical (Hoya Corporation), Richard Wolf GmbH, and TransEnterix, Inc., among others.
BIS Research is a global B2B market intelligence and advisory firm focusing on those emerging technological trends which are likely to disrupt the dynamics of the market.
With over 150 market research reports published annually, BIS Research focuses on high technology verticals such as 3D Printing, Advanced Materials and Chemicals, Aerospace and Defense, Automotive, Healthcare, Electronics and Semiconductors, Robotics and UAV, and other emerging technologies.
Our in-depth market intelligence reports focus on the market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More